ISRG Intuitive Surgical, Inc. - Common Stock
NASDAQ · Health Care · Lihat di SEC EDGAR ↗ tutup Okt 6, 2026 10-K/10-Q Jul 21, 2026ISRG Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
ISRG Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 5 Okt. 2021 | 3-for-1 | Maju |
| 6 Okt. 2017 | 3-for-1 | Maju |
| 1 Juli 2003 | 1-for-2 | Terbalik |
Tentang Intuitive Surgical, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Intuitive Surgical Inc. adalah sebuah perusahaan Amerika yang memproduksi sistem-sistem pembedahan robotik, terutama Sistem Pembedahan da Vinci. Sistem Pembedahan da Vinci membolehkan pembedahan yang ditunjukkan memakai manipulator robotik. Perusahaan tersebut adalah bagian dari NASDAQ-100 dan S&P 500. Intuitive Surgical telah menginstal lebih dari 1,242 sistem di seluruh dunia pada Juli 2009. Computer Motion adalah kompetitor yang bergabung dengan Intuitive Surgical pada 2003.
Referensi
Pranala luar
Situs web resmi
Intuitive Surgical Product Recalls by FDA
Data bisnis Intuitive Surgical:
Sumber: Wikipedia, CC BY-SA 4.0 · Lihat di Wikipedia ↗
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ISRG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 46.5rata-rata 5T ≈74.0 | ≈74.0 | 31.0 | Terlalu mahal | |
| P/S (TTM) | 13.0rata-rata 5T ≈19.3 | ≈19.3 | 5.0 | Terlalu mahal | |
| P/B (MRQ) | 7.9rata-rata 5T ≈10.2 | ≈10.2 | 5.0 | Terlalu mahal | |
| Harga / FCF (TTM) | 44.4rata-rata 5T ≈110.6 | ≈110.6 | · | · | |
| Harga / Arus Kas (TTM) | 38.6rata-rata 5T ≈66.6 | ≈66.6 | 26.4 | Terlalu mahal | |
| Harga / Nilai Buku Berwujud (MRQ) | 8.0rata-rata 5T ≈10.4 | ≈10.4 | · | · | |
| PEG Ratio (Rasio PEG) | ≈2.1 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ISRG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Kotor (TTM) | 66.7%rata-rata 5T ≈67.3% | ≈67.3% | 65.9% | Sejajar | |
| Margin Operasi (TTM) | 31.3%rata-rata 5T ≈27.9% | ≈27.9% | 24.8% | Tingkat teratas | |
| EBITDA Margin (Margin EBITDA) | 29.3%rata-rata 5T ≈27.9% | ≈27.9% | 29.5% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | 34.5%rata-rata 5T ≈30.3% | ≈30.3% | 24.0% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | 28.4%rata-rata 5T ≈26.5% | ≈26.5% | 17.8% | Tingkat teratas | |
| ROA (TTM) | 15.3%rata-rata 5T ≈12.9% | ≈12.9% | 7.9% | Tingkat teratas | |
| ROE (TTM) | 17.4%rata-rata 5T ≈14.9% | ≈14.9% | 15.9% | Sejajar | |
| ROIC | 14.4%rata-rata 5T ≈13.0% | ≈13.0% | 11.5% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ISRG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 5.0rata-rata 5T ≈4.6 | ≈4.6 | 1.6 | Likuiditas kuat | |
| Rasio Cepat (MRQ) | 3.6rata-rata 5T ≈3.7 | ≈3.7 | 0.9 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | ISRG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 20.5%rata-rata 5T ≈18.4% | ≈18.4% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 17.4%rata-rata 5T ≈16.2% | ≈16.2% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 18.2% | · | · | · | |
| EPS YoY | 22.6%rata-rata 5T ≈25.0% | ≈25.0% | · | · | |
| Net Income YoY (Laba Bersih YoY) | 23.0%rata-rata 5T ≈25.3% | ≈25.3% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3T) | 29.2%rata-rata 5T ≈20.0% | ≈20.0% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5T) | 21.8% | · | · | · | |
| Net Income CAGR 3Y (CAGR Laba Bersih 3T) | 29.3%rata-rata 5T ≈19.8% | ≈19.8% | · | · | |
| Net Income CAGR 5Y (CAGR Laba Bersih 5T) | 21.9% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | ISRG | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.5rata-rata 5T ≈0.5 | ≈0.5 | 0.5 | Lemah | |
| Inventory Turnover (Perputaran Persediaan) | 2.1rata-rata 5T ≈2.4 | ≈2.4 | 2.4 | Lemah | |
| Receivables Turnover (Perputaran Piutang) | 7.3rata-rata 5T ≈7.3 | ≈7.3 | 6.8 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$591.3K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Jul 16, 2026 | $2.80 | $2.55 | 9.8% |
| 31 Maret 2026 | $2.50 | $2.14 | 16.8% | |
| 31 Des. 2025 | $2.53 | $2.30 | 9.9% | |
| 30 Sep. 2025 | $2.40 | $2.02 | 18.7% | |
| 30 Juni 2025 | $2.19 | $1.96 | 11.6% | |
| 31 Maret 2025 | $1.81 | $1.76 | 3.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B | $4.48B | $3.72B | $3.14B | $2.71B | $2.38B | $2.13B | |
| Cost of Revenue | $3.42B | $2.72B | $2.39B | $2.03B | $1.75B | $1.50B | $1.37B | $1.12B | $936M | $814M | $806M | $718M | |
| Gross Profit | $6.64B | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B | $3.11B | $2.60B | $2.20B | $1.89B | $1.58B | $1.41B | |
| R&D Expense | $1.31B | $1.15B | $999M | $879M | $671M | $595M | $557M | $418M | $329M | $240M | $197M | $178M | |
| SG&A Expense | $2.38B | $2.14B | $1.96B | $1.74B | $1.47B | $1.22B | $1.18B | $987M | $810M | $704M | $640M | $691M | |
| Operating Expenses | $3.70B | $3.29B | $2.96B | $2.62B | $2.14B | $1.81B | $1.74B | $1.40B | $1.14B | $943M | $838M | $869M | |
| Operating Income | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B | $1.37B | $1.20B | $1.06B | $950M | $740M | $545M | |
| Other Non-op | $366M | $325M | $192M | $30M | $69M | $157M | $128M | $80M | $42M | $36M | $18M | $4M | |
| Pretax Income | $3.31B | $2.67B | $1.96B | $1.61B | $1.89B | $1.21B | $1.50B | $1.28B | $1.10B | $985M | $758M | $549M | |
| Income Tax | $435M | $336M | $142M | $262M | $162M | $140M | $120M | $154M | $434M | $247M | $170M | $130M | |
| Net Income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B | $1.38B | $1.13B | $671M | $738M | $589M | $419M | |
| EPS (Basic) | $8.00 | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 | $3.98 | $9.92 | $6.01 | $6.43 | $5.29 | $11.35 | |
| EPS (Diluted) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $9.49 | $5.77 | $6.26 | $5.18 | $11.11 | |
| Shares (Basic) | 356,900,000 | 355,200,000 | 351,200,000 | 355,700,000 | 356,100,000 | 351,100,000 | 346,200,000 | 113,700,000 | 111,700,000 | 114,900,000 | 111,300,000 | 36,900,000 | |
| Shares (Diluted) | 362,700,000 | 362,000,000 | 357,400,000 | 362,000,000 | 365,800,000 | 361,000,000 | 358,400,000 | 118,800,000 | 116,300,000 | 117,900,000 | 113,700,000 | 37,700,000 | |
| EBITDA | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B | $1.37B | $1.20B | $1.05B | $945M | $740M | $545M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.37B | $2.03B | $2.75B | $1.58B | $1.29B | $1.62B | $1.17B | $858M | $648M | $1.04B | $715M | $600M | |
| Short-term Investments | $2.57B | $1.99B | $2.47B | $2.54B | $2.91B | $3.49B | $2.05B | $2.21B | $1.31B | $1.52B | $845M | $632M | |
| Receivables | $1.53B | $1.23B | $1.13B | $942M | $783M | $646M | $645M | $682M | $508M | $430M | $394M | $315M | |
| Inventory | $1.84B | $1.49B | $1.22B | $893M | $587M | $602M | $596M | $409M | $241M | $182M | $168M | $182M | |
| Prepaid Expense | $477M | $385M | $314M | $300M | $271M | $268M | $200M | $179M | $99M | $83M | $74M | $83M | |
| Current Assets | $9.78B | $7.11B | $7.89B | $6.25B | $5.84B | $6.63B | $4.66B | $4.33B | $2.81B | $3.25B | $2.20B | $1.81B | |
| PP&E (Net) | $5.34B | $4.65B | $3.54B | $2.37B | $1.88B | $1.58B | $1.27B | $812M | $613M | $458M | $432M | $387M | |
| PP&E (Gross) | $7.62B | $6.53B | $5.10B | $3.61B | $2.85B | $2.33B | $1.84B | $1.25B | $960M | $780M | $699M | $610M | |
| Accum. Depreciation | $2.28B | $1.88B | $1.56B | $1.24B | $969M | $758M | $563M | $436M | $347M | $322M | $267M | $223M | |
| Goodwill | $370M | $348M | $349M | $348M | $344M | $337M | $307M | $241M | $201M | $201M | $201M | $198M | |
| Intangibles | $17M | $23M | $39M | $50M | $70M | $77M | $112M | $67M | $26M | $32M | $50M | $74M | |
| Total Assets | $20.46B | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B | $9.73B | $7.85B | $5.78B | $6.49B | $4.91B | $3.96B | |
| Accounts Payable | $255M | $193M | $189M | $147M | $121M | $82M | $124M | $101M | $82M | $68M | $53M | $62M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $170M | $151M | $96M | $127M | |
| Current Liabilities | $2.01B | $1.75B | $1.66B | $1.42B | $1.15B | $965M | $1.03B | $821M | $663M | $596M | $492M | $501M | |
| Capital Leases | $132M | $112M | $64M | $70M | $67M | $58M | $69M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $22M | $113M | $96M | $79M | |
| Total Liabilities | $2.52B | $2.21B | $2.04B | $1.86B | $1.60B | $1.41B | $1.45B | $1.16B | $996M | $709M | $588M | $580M | |
| Common Stock | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $100.0K | $100.0K | $100.0K | $0 | $0 | $0 | |
| Retained Earnings | $7.01B | $6.80B | $4.74B | $3.50B | $4.76B | $3.26B | $2.49B | $1.52B | $115M | $1.57B | $899M | $488M | |
| AOCI | $43M | $-51M | $-12M | $-162M | $-24M | $25M | $12M | $-13M | $-16M | $-9M | $-10M | $-5M | |
| Stockholders' Equity | $17.82B | $16.43B | $13.31B | $11.04B | $11.90B | $9.73B | $8.26B | $6.68B | $4.78B | $5.78B | $4.32B | $3.38B | |
| Liabilities + Equity | $20.46B | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B | $9.73B | $7.85B | $5.78B | $6.49B | $4.91B | $3.96B | |
| Shares Outstanding | 355,100,000 | 356,600,000 | 352,300,000 | 350,000,000 | 357,700,000 | 353,100,000 | 347,900,000 | 343,400,000 | 112,300,000 | 38,800,000 | 37,400,000 | 36,600,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $788M | $677M | $593M | $513M | $449M | $395M | $336M | $261M | $209M | $178M | $168M | $169M | |
| Deferred Tax | $19M | $-135M | $-281M | $-185M | $-64M | $58M | $-6M | $34M | $60M | $21M | $5M | $-35M | |
| Amort. of Intangibles | $13M | $17M | $20M | $28M | $27M | $50M | $43M | $14M | $13M | $18M | $24M | $22M | |
| Operating Cash Flow | $3.03B | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B | $1.60B | $1.17B | $1.14B | $1.09B | $806M | $665M | |
| CapEx | $540M | $1.11B | $1.06B | $532M | $340M | $342M | $426M | $187M | $191M | $54M | $81M | $106M | |
| Investing Cash Flow | $666M | $-3.27B | $-360M | $1.37B | $-2.46B | $-941M | $-1.15B | $-1.05B | $379M | $-1.28B | $-850M | $-154M | |
| Stock Repurchased | $2.30B | $0 | $416M | $2.61B | $0 | $134M | $270M | $0 | $2.27B | $42M | $184M | $1.00B | |
| Net Stock Activity | $-2.30B | $0 | $-416M | $-2.61B | $0 | $-134M | $-270M | $0 | $-2.27B | $-42M | $-184M | $-1.00B | |
| Financing Cash Flow | $-2.36B | $151M | $-288M | $-2.57B | $43M | $-86M | $-168M | $126M | $-1.91B | $514M | $159M | $-692M | |
| Net Change in Cash | $1.34B | $-708M | $1.17B | $295M | $-332M | $456M | $273M | $246M | $-388M | $322M | $114M | $-182M | |
| Taxes Paid | $538M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $2.49B | $1.30B | $750M | $958M | $1.74B | $1.14B | $1.17B | $982M | $953M | $989M | $691M | $560M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | 65.6% | 69.5% | 69.9% | 70.1% | 69.9% | 66.2% | 66.3% | |
| Operating Margin | 29.3% | 28.1% | 24.8% | 25.4% | 31.9% | 24.1% | 30.7% | 32.2% | 33.7% | 34.9% | 31.0% | 25.6% | |
| Net Margin | 28.4% | 27.8% | 25.2% | 21.2% | 29.8% | 24.3% | 30.8% | 30.3% | 21.1% | 27.2% | 24.7% | 19.7% | |
| Pretax Margin | 32.9% | 32.0% | 27.5% | 25.8% | 33.1% | 27.7% | 33.5% | 34.4% | 35.0% | 36.3% | 31.8% | 25.8% | |
| EBITDA Margin | 29.3% | 28.1% | 24.8% | 25.4% | 31.9% | 24.1% | 30.7% | 32.2% | 33.7% | 34.9% | 31.0% | 25.6% | |
| ROA | 14.6% | 13.6% | 12.7% | 10.0% | 13.8% | 10.2% | 15.7% | 16.6% | 10.8% | 12.9% | 13.3% | 10.6% | |
| ROE | 16.7% | 15.6% | 14.8% | 11.5% | 15.8% | 11.8% | 18.5% | 19.7% | 12.6% | 14.6% | 15.3% | 12.2% | |
| ROIC | 14.4% | 12.5% | 12.3% | 11.9% | 14.0% | 9.5% | 15.3% | 15.8% | 13.4% | 12.3% | 13.3% | 12.3% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 4.1 | 4.8 | 4.4 | 5.1 | 6.9 | 4.5 | 5.3 | 4.0 | 5.4 | 4.5 | 3.7 | |
| Quick Ratio | 3.7 | 3.0 | 3.8 | 3.6 | 4.3 | 6.0 | 3.8 | 4.6 | 3.5 | 5.0 | 4.0 | 3.1 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Inventory Turnover | 2.1 | 2.0 | 2.3 | 2.7 | 2.9 | 2.5 | 2.7 | 3.4 | 4.4 | 4.7 | 4.6 | 4.0 | |
| Receivables Turnover | 7.3 | 7.1 | 6.9 | 7.2 | 8.0 | 6.8 | 6.7 | 6.3 | 6.6 | 6.6 | 6.7 | 6.9 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $50.19 | $46.08 | $37.77 | $31.55 | $33.27 | $82.68 | $71.24 | $58.33 | $42.08 | $148.91 | $115.49 | $92.33 | |
| Revenue / Share | $27.75 | $23.07 | $19.93 | $17.19 | $15.61 | $36.23 | $37.48 | $31.35 | $26.90 | $68.81 | $62.91 | $56.54 | |
| Cash Flow / Share | $8.36 | $6.67 | $5.08 | $4.12 | $5.71 | $12.34 | $13.37 | $9.85 | $9.84 | $26.54 | $20.37 | $17.64 | |
| Cash / Share | $9.48 | $5.69 | $7.81 | $4.52 | $3.61 | $13.79 | $10.07 | $7.49 | $5.77 | $26.72 | $19.11 | $16.40 | |
| EPS (TTM) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $9.49 | $5.77 | $6.26 | $5.18 | $11.11 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.5% | 17.2% | 14.5% | 9.0% | 31.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.4% | 13.5% | 17.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 22.6% | 27.6% | 37.8% | -21.7% | 58.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 29.2% | 11.3% | 19.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 23.0% | 29.2% | 36.0% | -22.4% | 60.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 29.3% | 10.9% | 19.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 21.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B | $4.48B | $3.72B | $3.14B | $2.71B | $2.38B | $2.13B | |
| Net Income TTM | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B | $1.38B | $1.13B | $671M | $738M | $589M | $419M | |
| Market Cap | $201.11B | $186.13B | $118.85B | $92.87B | $128.52B | $32.10B | $22.86B | $18.28B | $13.66B | $2.73B | $2.27B | $2.15B | |
| P/E | 72.0 | 81.3 | 67.1 | 72.7 | 77.1 | 92.8 | 51.2 | 16.8 | 21.1 | 11.3 | 11.7 | 5.3 | |
| P/S | 20.0 | 22.3 | 16.7 | 14.9 | 22.5 | 7.4 | 5.1 | 4.9 | 4.4 | 1.0 | 1.0 | 1.0 | |
| P/B | 11.3 | 11.3 | 8.9 | 8.4 | 10.8 | 3.3 | 2.8 | 2.7 | 2.9 | 0.5 | 0.5 | 0.6 | |
| P / Tangible Book | 11.5 | 11.6 | 9.2 | 8.7 | 11.2 | 3.4 | · | · | · | · | · | · | |
| P / Cash Flow | 66.4 | 77.1 | 65.5 | 62.3 | 61.5 | 21.6 | 14.3 | 15.6 | 11.9 | 2.6 | 2.9 | 3.2 | |
| P / FCF | 80.7 | 142.8 | 158.6 | 96.9 | 74.0 | 28.1 | 19.5 | 18.6 | 14.3 | 2.8 | 3.3 | 3.8 | |
| Earnings Yield | 1.4% | 1.2% | 1.5% | 1.4% | 1.3% | 1.1% | 1.9% | 5.9% | 4.7% | 8.9% | 8.5% | 18.9% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | $2.25B | $2.41B | $2.04B | $2.01B | $1.89B | $1.93B | $1.74B | $1.76B | $1.70B | $1.66B | $1.56B | |
| Cost of Revenue | $932M | $940M | $962M | $843M | $822M | $796M | $771M | $664M | $637M | $645M | $651M | $576M | $584M | $583M | $544M | $505M | |
| Gross Profit | $1.96B | $1.83B | $1.90B | $1.66B | $1.62B | $1.46B | $1.64B | $1.37B | $1.37B | $1.25B | $1.28B | $1.17B | $1.17B | $1.11B | $1.11B | $1.05B | |
| R&D Expense | $371M | $362M | $353M | $329M | $313M | $316M | $295M | $286M | $280M | $284M | $260M | $249M | $244M | $245M | $244M | $217M | |
| SG&A Expense | $618M | $613M | $687M | $573M | $561M | $563M | $613M | $511M | $525M | $492M | $567M | $452M | $464M | $480M | $494M | $436M | |
| Operating Expenses | $988M | $975M | $1.04B | $903M | $874M | $880M | $907M | $797M | $805M | $776M | $827M | $701M | $709M | $725M | $738M | $653M | |
| Operating Income | $972M | $855M | $864M | $760M | $743M | $578M | $735M | $577M | $567M | $469M | $450M | $466M | $463M | $388M | $372M | $399M | |
| Other Non-op | $83M | $85M | $91M | $96M | $89M | $90M | $75M | $94M | $87M | $69M | $66M | $56M | $36M | $34M | $22M | $4M | |
| Pretax Income | $1.05B | $940M | $956M | $855M | $832M | $668M | $810M | $671M | $654M | $538M | $516M | $522M | $499M | $422M | $395M | $403M | |
| Income Tax | $231M | $114M | $156M | $146M | $168M | $-35M | $122M | $100M | $123M | $-9M | $-95M | $102M | $73M | $61M | $58M | $78M | |
| Net Income | $818M | $822M | $795M | $704M | $658M | $698M | $686M | $565M | $527M | $545M | $606M | $416M | $421M | $355M | $325M | $324M | |
| EPS (Basic) | $2.31 | $2.31 | $2.23 | $1.98 | $1.84 | $1.95 | $1.93 | $1.59 | $1.48 | $1.54 | $1.73 | $1.18 | $1.20 | $1.01 | $0.93 | $0.91 | |
| EPS (Diluted) | $2.29 | $2.28 | $2.19 | $1.95 | $1.81 | $1.92 | $1.89 | $1.56 | $1.46 | $1.51 | $1.69 | $1.16 | $1.18 | $1.00 | $0.90 | $0.90 | |
| Shares (Basic) | 354,100,000 | 354,900,000 | · | 356,600,000 | 358,500,000 | 357,500,000 | · | 355,800,000 | 355,000,000 | 353,500,000 | · | 351,700,000 | 350,900,000 | 350,200,000 | · | 355,300,000 | |
| Shares (Diluted) | 357,300,000 | 359,800,000 | · | 361,800,000 | 364,100,000 | 364,600,000 | · | 362,700,000 | 361,000,000 | 360,500,000 | · | 358,200,000 | 357,300,000 | 356,000,000 | · | 360,500,000 | |
| EBITDA | $972M | $855M | · | $760M | $743M | $578M | · | $577M | $567M | $469M | · | $466M | $463M | $388M | · | $399M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.76B | $2.01B | $3.37B | $2.81B | $3.40B | $2.57B | $2.03B | $2.41B | $3.04B | $2.84B | · | $3.60B | $3.44B | $2.14B | · | $1.54B | |
| Short-term Investments | $2.46B | $2.51B | $2.57B | $2.10B | $1.92B | $1.94B | $1.99B | $1.82B | $1.72B | $1.96B | · | $2.87B | $2.36B | $2.55B | · | $2.78B | |
| Receivables | $1.67B | $1.60B | $1.53B | $1.26B | $1.27B | $1.22B | $1.23B | $1.15B | $1.11B | $1.13B | · | $963M | $904M | $925M | · | $850M | |
| Inventory | $2.03B | $1.95B | $1.84B | $1.78B | $1.67B | $1.55B | $1.49B | $1.48B | $1.38B | $1.30B | · | $1.15B | $1.01B | $947M | · | $837M | |
| Prepaid Expense | $625M | $752M | $477M | $575M | $483M | $371M | $385M | $349M | $404M | $405M | · | $317M | $323M | $313M | · | $292M | |
| Current Assets | $9.54B | $8.81B | $9.78B | $8.53B | $8.75B | $7.66B | $7.11B | $7.22B | $7.65B | $7.63B | · | $8.90B | $8.03B | $6.88B | · | $6.29B | |
| PP&E (Net) | $5.55B | $5.45B | $5.34B | $5.15B | $4.99B | $4.80B | $4.65B | $4.43B | $4.12B | $3.80B | · | $3.08B | $2.83B | $2.58B | · | $2.24B | |
| PP&E (Gross) | · | · | $7.62B | · | · | · | $6.53B | $6.24B | · | · | · | $4.55B | · | · | · | · | |
| Accum. Depreciation | · | · | $2.28B | · | · | · | $1.88B | $1.81B | · | · | · | $1.47B | · | · | · | · | |
| Goodwill | $581M | $613M | $370M | $348M | $349M | $348M | $348M | $348M | $348M | $348M | $349M | $348M | $349M | $349M | $348M | $348M | |
| Intangibles | $198M | $174M | $17M | $14M | $18M | $20M | $23M | $25M | $29M | $34M | · | $42M | $47M | $45M | · | $57M | |
| Total Assets | $20.88B | $20.11B | $20.46B | $19.35B | $20.16B | $19.22B | $18.74B | $17.74B | $16.65B | $15.83B | · | $14.71B | $13.90B | $13.05B | · | $13.26B | |
| Accounts Payable | $277M | $333M | $255M | $291M | $267M | $276M | $193M | $219M | $194M | $194M | · | $196M | $200M | $164M | · | $164M | |
| Current Liabilities | $1.92B | $1.91B | $2.01B | $1.80B | $1.69B | $1.54B | $1.75B | $1.68B | $1.49B | $1.38B | · | $1.68B | $1.54B | $1.31B | · | $1.23B | |
| Capital Leases | · | · | $132M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $2.58B | $2.51B | $2.52B | $2.31B | $2.21B | $2.01B | $2.21B | $2.07B | $1.85B | $1.78B | · | $2.09B | $1.94B | $1.76B | · | $1.69B | |
| Common Stock | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | · | $400.0K | $400.0K | $400.0K | · | $400.0K | |
| Retained Earnings | $6.84B | $6.40B | $7.01B | $6.42B | $7.61B | $7.14B | $6.80B | $6.13B | $5.58B | $5.07B | · | $4.21B | $3.81B | $3.40B | · | $4.02B | |
| AOCI | $6M | $16M | $43M | $26M | $3M | $-27M | $-51M | $13M | $-24M | $-9M | · | $-56M | $-80M | $-108M | · | $-188M | |
| Stockholders' Equity | $18.17B | $17.47B | $17.82B | $16.93B | $17.85B | $17.11B | $16.43B | $15.58B | $14.71B | $13.96B | · | $12.54B | $11.88B | $11.22B | · | $11.52B | |
| Liabilities + Equity | $20.88B | $20.11B | $20.46B | $19.35B | $20.16B | $19.22B | $18.74B | $17.74B | $16.65B | $15.83B | · | $14.71B | $13.90B | $13.05B | · | $13.26B | |
| Shares Outstanding | 353,900,000 | 354,400,000 | 355,100,000 | 354,900,000 | 358,400,000 | 358,400,000 | 356,600,000 | 356,200,000 | 355,300,000 | 354,700,000 | 352,300,000 | 352,000,000 | 351,300,000 | 350,400,000 | 350,000,000 | 353,300,000 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $210M | $210M | $203M | $204M | $196M | $185M | $177M | $173M | $174M | $153M | $150M | $156M | $146M | $140M | $128M | $138M | |
| Amort. of Intangibles | $24M | $7M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $8M | $8M | |
| Operating Cash Flow | $1.06B | $912M | $892M | $841M | $715M | $582M | $823M | $706M | $620M | $265M | $228M | $548M | $666M | $371M | $438M | $383M | |
| CapEx | $113M | $103M | $162M | $105M | $155M | $117M | $312M | $248M | $309M | $242M | $436M | $256M | $178M | $194M | $139M | $168M | |
| Investing Cash Flow | $-27M | $-914M | $-209M | $401M | $261M | $214M | $-1.26B | $-1.41B | $-467M | $-128M | $-1.04B | $-447M | $558M | $573M | $575M | $544M | |
| Stock Repurchased | $320M | $1.12B | $201M | $1.91B | $181M | $0 | $0 | $0 | $0 | $0 | $66M | $0 | $0 | $350M | $1.00B | $1.00B | |
| Net Stock Activity | · | $-1.12B | · | · | · | · | · | · | · | $0 | · | · | · | $-350M | · | · | |
| Dividends Paid | · | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $-288M | $-1.35B | $-138M | $-1.84B | $-148M | $-236M | $49M | $98M | $50M | $-47M | $-32M | $62M | $63M | $-381M | $-964M | $-927M | |
| Net Change in Cash | $754M | $-1.36B | $558M | $-597M | $829M | $555M | $-384M | $-620M | $200M | $97M | $-853M | $165M | $1.29B | $565M | $47M | $3M | |
| Free Cash Flow | · | $809M | · | · | · | $465M | · | · | · | $24M | · | · | · | $177M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.8% | 66.1% | · | 66.4% | 66.3% | 64.7% | · | 67.4% | 68.3% | 65.9% | · | 66.9% | 66.7% | 65.6% | · | 67.5% | |
| Operating Margin | 33.6% | 30.9% | · | 30.3% | 30.5% | 25.7% | · | 28.3% | 28.2% | 24.8% | · | 26.7% | 26.4% | 22.9% | · | 25.6% | |
| Net Margin | 28.3% | 29.6% | · | 28.1% | 27.0% | 31.0% | · | 27.7% | 26.2% | 28.8% | · | 23.8% | 24.0% | 20.9% | · | 20.8% | |
| Pretax Margin | 36.5% | 33.9% | · | 34.1% | 34.1% | 29.7% | · | 32.9% | 32.6% | 28.5% | · | 29.9% | 28.4% | 24.9% | · | 25.9% | |
| EBITDA Margin | 33.6% | 30.9% | · | 30.3% | 30.5% | 25.7% | · | 28.3% | 28.2% | 24.8% | · | 26.7% | 26.4% | 22.9% | · | 25.6% | |
| ROA | 4.0% | 4.2% | · | 3.8% | 3.6% | 4.0% | · | 3.5% | 3.5% | 3.8% | · | 3.0% | 3.0% | 2.7% | · | 2.5% | |
| ROE | 4.5% | 4.8% | · | 4.3% | 4.0% | 4.5% | · | 4.0% | 4.0% | 4.3% | · | 3.5% | 3.5% | 3.0% | · | 2.8% | |
| ROIC | 4.2% | 4.3% | · | 3.7% | 3.3% | 3.6% | · | 3.1% | 3.1% | 3.4% | · | 3.0% | 3.3% | 3.0% | · | 2.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.6 | · | 4.7 | 5.2 | 5.0 | · | 4.3 | 5.1 | 5.6 | · | 5.3 | 5.2 | 5.3 | · | 5.1 | |
| Quick Ratio | 3.6 | 3.2 | · | 3.4 | 3.9 | 3.7 | · | 3.2 | 3.9 | 4.3 | · | 4.4 | 4.4 | 4.3 | · | 4.2 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.1 | 2.1 | 1.9 | · | 1.9 | 2.0 | 1.8 | · | 1.9 | 2.0 | 1.9 | · | 2.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $51.34 | $49.31 | · | $47.70 | $49.79 | $47.73 | · | $43.75 | $41.40 | $39.36 | · | $35.62 | $33.81 | $32.01 | · | $32.59 | |
| Revenue / Share | $8.09 | $7.70 | · | $6.92 | $6.70 | $6.18 | · | $5.62 | $5.57 | $5.24 | · | $4.87 | $4.91 | $4.76 | · | $4.32 | |
| Cash Flow / Share | · | $2.53 | · | · | · | $1.60 | · | · | · | $0.74 | · | · | · | $1.04 | · | · | |
| Cash / Share | $7.80 | $5.66 | · | $7.91 | $9.50 | $7.18 | · | $6.78 | $8.55 | $8.01 | · | $10.23 | $9.78 | $6.12 | · | $4.35 | |
| EPS (TTM) | $8.33 | $8.23 | · | $7.57 | $7.18 | $6.83 | · | $6.22 | $5.82 | $5.54 | · | $4.24 | $3.98 | $3.65 | · | $3.78 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.03B | $10.58B | · | $9.61B | $9.14B | $8.71B | · | $7.87B | $7.57B | $7.32B | · | $6.85B | $6.66B | $6.43B | · | $6.12B | |
| Net Income TTM | $3.14B | $2.98B | · | $2.75B | $2.61B | $2.48B | · | $2.24B | $2.09B | $1.99B | · | $1.52B | $1.43B | $1.31B | · | $1.38B | |
| Market Cap | $140.74B | $163.37B | · | $158.72B | $194.76B | $177.50B | · | $174.99B | $158.06B | $141.56B | · | $102.89B | $120.12B | $89.52B | · | $66.22B | |
| P/E | 45.7 | 56.0 | · | 59.1 | 75.7 | 72.5 | · | 79.0 | 76.4 | 72.0 | · | 68.9 | 85.9 | 70.0 | · | 49.6 | |
| P/S | 12.8 | 15.4 | · | 16.5 | 21.3 | 20.4 | · | 22.2 | 20.9 | 19.3 | · | 15.0 | 18.0 | 13.9 | · | 10.8 | |
| P/B | 7.7 | 9.3 | · | 9.4 | 10.9 | 10.4 | · | 11.2 | 10.7 | 10.1 | · | 8.2 | 10.1 | 8.0 | · | 5.8 | |
| P / Tangible Book | 8.1 | 9.8 | · | 9.6 | 11.1 | 10.6 | · | 11.5 | 11.0 | 10.4 | · | 8.5 | 10.5 | 8.3 | · | 6.0 | |
| P / Cash Flow | · | 179.2 | · | · | · | 305.2 | · | · | · | 533.4 | · | · | · | 241.0 | · | · | |
| Earnings Yield | 2.2% | 1.8% | · | 1.7% | 1.3% | 1.4% | · | 1.3% | 1.3% | 1.4% | · | 1.5% | 1.2% | 1.4% | · | 2.0% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B |
| Margin Kotor % | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% |
| Margin Operasi % | 29.3% | 28.1% | 24.8% | 25.4% | 31.9% |
| Laba Bersih | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B |
| EPS Dilusian | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 4.9 | 4.1 | 4.8 | 4.4 | 5.1 |
| Rasio Cepat | 3.7 | 3.0 | 3.8 | 3.6 | 4.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $2.49B | $1.30B | $750M | $958M | $1.74B |
Pemilik institusional (13F) 2.455 pengaju · $139.7B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 172 (-42 vs Kuartal sebelumnya) | 196 (-35 vs Kuartal sebelumnya) | 911 (-86 vs Kuartal sebelumnya) | 893 (+60 vs Kuartal sebelumnya) | +7.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD GROUP INC | $19.037.227.455 | 33.613.298 | 13,63% | Saham |
| BlackRock, Inc. | $11.940.201.916 | 30.024.648 | 8,55% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.198.775.450 | 23.131.099 | 6,59% | Saham |
| STATE STREET CORP | $6.387.949.747 | 16.063.040 | 4,57% | Saham |
| Invesco Ltd. | $4.709.948.094 | 11.843.563 | 3,37% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $3.380.563.364 | 8.534.767 | 2,42% | Saham |
| Capital World Investors | $3.079.329.501 | 7.742.681 | 2,20% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.880.501.227 | 7.243.264 | 2,06% | Saham |
| MORGAN STANLEY | $2.609.308.152 | 6.561.322 | 1,87% | Saham |
| NORGES BANK | $1.970.454.292 | 4.954.874 | 1,41% | Saham |
| JPMORGAN CHASE & CO | $1.717.673.063 | 4.231.033 | 1,23% | Saham |
| FMR LLC | $1.690.589.691 | 4.251.130 | 1,21% | Saham |
| ALLIANCEBERNSTEIN L.P. | $1.673.136.468 | 3.629.442 | 1,20% | Saham |
| Fisher Asset Management, LLC | $1.558.444.582 | 3.918.840 | 1,12% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1.528.761.776 | 3.316.258 | 1,09% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.511.980.554 | 3.802.003 | 1,08% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.489.111.567 | 3.744.497 | 1,07% | Saham |
| JENNISON ASSOCIATES LLC | $1.459.171.817 | 3.669.211 | 1,04% | Saham |
| NORTHERN TRUST CORP | $1.397.048.249 | 3.512.996 | 1,00% | Saham |
| BANK OF AMERICA CORP /DE/ | $1.353.606.951 | 3.403.759 | 0,97% | Saham |
| Bank of New York Mellon Corp | $1.335.752.583 | 3.358.863 | 0,96% | Saham |
| GOLDMAN SACHS GROUP INC | $1.150.041.824 | 2.891.877 | 0,82% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.114.525.243 | 2.802.568 | 0,80% | Saham |
| Nuveen, LLC | $1.072.397.277 | 2.696.634 | 0,77% | Saham |
| Amundi | $1.068.008.595 | 2.685.598 | 0,76% | Saham |
| BAILLIE GIFFORD & CO | $1.003.914.130 | 2.524.427 | 0,72% | Saham |
| Legal & General Group Plc | $985.651.869 | 2.478.505 | 0,71% | Saham |
| FRANKLIN RESOURCES INC | $893.810.054 | 2.247.561 | 0,64% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $809.203.241 | 2.034.810 | 0,58% | Saham |
| AMERICAN CENTURY COMPANIES INC | $801.166.368 | 2.014.594 | 0,57% | Saham |
| TWO SIGMA INVESTMENTS, LP | $787.059.623 | 1.979.128 | 0,56% | Saham |
| JANUS HENDERSON GROUP PLC | $757.489.182 | 1.643.060 | 0,54% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $714.193.512 | 1.795.900 | 0,51% | Opsi beli |
| UBS Group AG | $707.291.776 | 1.778.545 | 0,51% | Saham |
| Sumitomo Mitsui Trust Group, Inc. | $679.810.497 | 1.709.441 | 0,49% | Saham |
| LOOMIS SAYLES & CO L P | $658.620.313 | 1.656.156 | 0,47% | Saham |
| ROYAL BANK OF CANADA | $622.202.000 | 1.564.576 | 0,45% | Saham |
| Capital Research Global Investors | $617.065.740 | 1.551.664 | 0,44% | Saham |
| TWO SIGMA ADVISERS, LP | $604.056.922 | 1.066.560 | 0,43% | Saham |
| CANADA PENSION PLAN INVESTMENT BOARD | $603.306.012 | 1.517.064 | 0,43% | Saham |
| DEUTSCHE BANK AG\ | $571.614.097 | 1.437.372 | 0,41% | Saham |
| Pictet Asset Management Holding SA | $547.639.823 | 1.376.925 | 0,39% | Saham |
| AMERIPRISE FINANCIAL INC | $527.960.472 | 1.327.623 | 0,38% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $527.641.824 | 1.326.800 | 0,38% | Opsi jual |
| VICTORY CAPITAL MANAGEMENT INC | $517.355.105 | 1.300.881 | 0,37% | Saham |
| SANDS CAPITAL MANAGEMENT, LLC | $498.063.976 | 1.252.424 | 0,36% | Saham |
| Grantham, Mayo, Van Otterloo & Co. LLC | $488.349.371 | 1.227.993 | 0,35% | Saham |
| Clearbridge Investments, LLC | $483.448.851 | 1.215.674 | 0,35% | Saham |
| BARCLAYS PLC | $482.817.322 | 1.214.085 | 0,35% | Saham |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $449.034.649 | 1.129.058 | 0,32% | Saham |
Orang dalam perusahaan 48 orang dalam · 20 pejabat · 18 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| David J. Rosa | Chief Executive Officer (CEO) | 10 Juli 2026 M | 246.856 | 0 | 1 | $-13.414.975 |
| Susan K Barnes | Former CFO | 11 Nov. 2005 M | 126.236 | 0 | 0 | $0 |
| Salvatore Brogna | EVP & Chief Operating Officer | 2 Des. 2019 M | 4.143 | 0 | 0 | $0 |
| Fredrik Widman | VP Corporate Controller | 15 Sep. 2026 M | 1.026 | 0 | 7 | $-1.792.360 |
| Mark Brosius | EVP & Chief Mfg and Supply Cha | 11 Sep. 2026 S | 764 | 0 | 33 | $-5.918.298 |
| Gary Loeb | EVP & Chief Legal and Complian | 10 Agu 2026 S | 5.320 | 0 | 3 | $-500.036 |
| Iman Jeddi | SVP & GM da Vinci Platforms & | 1 Juni 2026 M | 6.463 | 0 | 1 | $-2.365.594 |
| Myriam Curet | EVP & Chief Medical Officer | 10 Maret 2026 M | 0 | 0 | 16 | $-8.440.242 |
| Henry L Charlton | EVP & Chief Commercial and Mkt | 28 Feb. 2026 M | 11.610 | 0 | 5 | $-7.963.980 |
| Brian Edward Miller | EVP & Chief Digital Officer | 10 Nov. 2025 M | 5.758 | 0 | 2 | $-2.012.500 |
| Robert Desantis | EVP & Chief Strategy & Corp Op | 25 April 2025 M | 5.224 | 0 | 0 | $0 |
| Marshall Mohr | Executive VP Global Business S | 31 Agu 2024 F | 1.650 | 0 | 0 | $0 |
| Michele Dimartino | Officer Title: SVP and Chief Human Resources Officer | 28 Feb. 2023 A | 2.112 | 0 | 0 | $0 |
| Reiter Kara Andersen | Sr VP General Counsel & CCO | 29 Agu 2022 A | 18.067 | 0 | 0 | $0 |
| Mark J Meltzer | SVP General Counsel & CCO | 7 Juni 2018 M | 10.052 | 0 | 0 | $0 |
| Colin Morales | GM & SVP Secondary Mkt Equip & | 7 Feb. 2017 M | 124 | 0 | 0 | $0 |
| Jerome J Mcnamara | Sr Advisor - Commercial Ops | 27 Juli 2015 M | 3.213 | 0 | 0 | $0 |
| Richard Michael Epstein | Sr. Vice President, Marketing | 5 Feb. 2007 A | · | 0 | 0 | $0 |
| Eric Miller | Sr. Vice President | 4 Agu 2006 M | 0 | 0 | 0 | $0 |
| Benjamin B Gong | Vice President, Finance | 15 Feb. 2006 M | 6.495 | 0 | 0 | $0 |
| Amy L Ladd | Direktur | 11 Agu 2026 S | 179 | 0 | 4 | $-471.789 |
| Monica P Reed | Direktur | 30 April 2026 A | 2.876 | 0 | 0 | $0 |
| Sreelakshmi Kolli | Direktur | 30 April 2026 A | 1.510 | 0 | 0 | $0 |
| Keith R Leonard | Direktur | 30 April 2026 A | 901 | 0 | 0 | $0 |
| Lewis Chew | Direktur | 30 April 2026 A | 1.314 | 0 | 0 | $0 |
| Jami K Nachtsheim | Direktur | 30 April 2026 A | 6.902 | 0 | 0 | $0 |
| Mark J Rubash | Direktur | 25 April 2025 M | 16.790 | 0 | 0 | $0 |
| Alan J Levy | Direktur | 25 April 2024 M | 25.888 | 0 | 0 | $0 |
| Don R Kania | Direktur | 25 April 2024 M | 3.838 | 0 | 0 | $0 |
| Lonnie M Smith | Direktur | 23 April 2020 M | 277.069 | 0 | 0 | $0 |
| Michael A Friedman | Direktur | 23 April 2019 M | 4.751 | 0 | 0 | $0 |
| George Stalk JR | Direktur | 20 April 2017 M | 1.141 | 0 | 0 | $0 |
| Eric H Halvorson | Direktur | 25 April 2016 M | 2.485 | 0 | 0 | $0 |
| Floyd D Loop MD | Direktur | 30 Okt. 2014 M | 4.979 | 0 | 0 | $0 |
| William J Mercer | Direktur | 2 Juni 2006 M | 0 | 0 | 0 | $0 |
| William Clark Meyers | Direktur | 21 Mei 2004 A | · | 0 | 0 | $0 |
| Frederic H Moll | Direktur | 10 Sep. 2003 S | 657.799 | 0 | 0 | $0 |
| Gary S Guthart | · | 11 Agu 2026 S | 1.245.679 | 0 | 8 | $-48.794.707 |
| Amal M Johnson | · | 30 April 2026 M | 13.545 | 0 | 0 | $0 |
| Craig H Barratt | · | 30 April 2026 A | 27.948 | 0 | 2 | $-1.636.786 |
| Joseph C Beery | · | 30 April 2026 A | 3.641 | 0 | 0 | $0 |
| Jamie Samath | · | 28 Feb. 2026 M | 15.366 | 0 | 0 | $0 |
| Patricia L Wadors | · | 26 Feb. 2026 A | 0 | 0 | 1 | $-109.936 |
| Augusto V. Castello | · | 15 Feb. 2013 A | 0 | 0 | 0 | $0 |
| Robert W. Duggan | · | 18 Mei 2011 M | 1.000 | 0 | 0 | $0 |
| Keith D Grossman | · | 23 April 2010 M | 0 | 0 | 0 | $0 |
| Richard J Kramer | · | 16 Juli 2009 M | 1.000 | 0 | 0 | $0 |
| John F Runkel JR | · | 5 Maret 2008 M | 403 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 137 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IHI · iShares Trust | 13,29% | 1.171.267 SH | 11 Sep. 2026 | Harian |
| MEDI · Harbor ETF Trust | 2,83% | 3.300 NS | 31 Juli 2026 | N-PORT |
| QNXT · iShares Trust | 2,44% | 1.852 SH | 11 Sep. 2026 | Harian |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,09% | 8.827 SH | 5 Okt. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 2,08% | 1.067.681 SH | 19 Agu 2026 | Harian |
| IYH · iShares Trust | 2,05% | 206.344 SH | 11 Sep. 2026 | Harian |
| IGPT · Invesco Exchange-Traded Fund Trust | 2,01% | 75.164 SH | 5 Okt. 2026 | Harian |
| FGSI · First Trust Exchange-Traded Fund IV | 2,00% | 117 NS | 31 Juli 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,93% | 496 NS | 31 Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,83% | 40.872 SH | 5 Okt. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 1,82% | 168.952 NS | 31 Juli 2026 | N-PORT |
| CAML · Professionally Managed Portfolios | 1,63% | 16.992 NS | 31 Juli 2026 | N-PORT |
| IXJ · iShares Trust | 1,62% | 186.313 SH | 11 Sep. 2026 | Harian |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,55% | 87.192 NS | 31 Juli 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,50% | 2.934 NS | 31 Juli 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,43% | 6.969 NS | 31 Juli 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 1,37% | 657.638 SH | 5 Okt. 2026 | Harian |
| TECB · iShares Trust | 1,31% | 17.946 SH | 11 Sep. 2026 | Harian |
| ARKQ · ARK ETF Trust | 1,29% | 68.016 NS | 31 Juli 2026 | N-PORT |
| XT · iShares Trust | 1,22% | 131.150 SH | 11 Sep. 2026 | Harian |
| TEC · Harbor ETF Trust | 1,13% | 204 NS | 31 Juli 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,13% | 79.809 SH | 5 Okt. 2026 | Harian |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,03% | 3.282 NS | 31 Juli 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0,95% | 545 NS | 31 Juli 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0,88% | 1.046 NS | 31 Juli 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,86% | 60.667 NS | 31 Juli 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,85% | 32.011 NS | 31 Juli 2026 | N-PORT |
| ESLG · Strategy Shares | 0,84% | 554 NS | 31 Juli 2026 | N-PORT |
| JHAI · Janus Detroit Street Trust | 0,82% | 539 NS | 31 Juli 2026 | N-PORT |
| NUGO · Nushares ETF Trust | 0,76% | 52.249 NS | 31 Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,70% | 84.865 SH | 5 Okt. 2026 | Harian |
| ESUM · Strategy Shares | 0,68% | 3.516 NS | 31 Juli 2026 | N-PORT |
| MGK · VANGUARD WORLD FUND | 0,63% | 525.413 SH | 19 Agu 2026 | Harian |
| BIGY · Tidal Trust II | 0,63% | 967 NS | 31 Juli 2026 | N-PORT |
| GRZZ · Tidal Trust II | 0,61% | 575 NS | 31 Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,59% | 21.903 NS | 31 Juli 2026 | N-PORT |
| QRMI · Global X Funds | 0,59% | 238 NS | 31 Juli 2026 | N-PORT |
| QYLD · Global X Funds | 0,58% | 133.690 NS | 31 Juli 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,58% | 3.451 NS | 31 Juli 2026 | N-PORT |
| QYLG · Global X Funds | 0,58% | 2.594 NS | 31 Juli 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,57% | 19.367 NS | 31 Juli 2026 | N-PORT |
| QQQM · Invesco Exchange-Traded Fund Trust … | 0,57% | 1.630.173 SH | 5 Okt. 2026 | Harian |
| QQQ · Invesco QQQ Trust, Series 1 | 0,57% | 7.374.190 SH | 5 Okt. 2026 | Harian |
| QQWZ · Pacer Funds Trust | 0,57% | 821 NS | 31 Juli 2026 | N-PORT |
| QTR · Global X Funds | 0,57% | 122 NS | 31 Juli 2026 | N-PORT |
| QCLR · Global X Funds | 0,56% | 52 NS | 31 Juli 2026 | N-PORT |
| QSIX · Pacer Funds Trust | 0,53% | 273 NS | 31 Juli 2026 | N-PORT |
| RPG · Invesco Exchange-Traded Fund Trust | 0,49% | 24.296 SH | 5 Okt. 2026 | Harian |
| IWY · iShares Trust | 0,45% | 193.645 SH | 11 Sep. 2026 | Harian |
| ESG · FlexShares Trust | 0,44% | 1.650 NS | 31 Juli 2026 | N-PORT |
| RGEF · Tidal Trust III | 0,44% | 10.035 NS | 31 Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,42% | 558.534 SH | 19 Agu 2026 | Harian |
| OEI · Listed Funds Trust | 0,41% | 537 NS | 31 Juli 2026 | N-PORT |
| VUG · VANGUARD INDEX FUNDS | 0,40% | 3.844.783 SH | 19 Agu 2026 | Harian |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,40% | 263.157 SH | 19 Agu 2026 | Harian |
| ILCG · iShares Trust | 0,40% | 34.375 SH | 11 Sep. 2026 | Harian |
| COWG · Pacer Funds Trust | 0,39% | 24.349 NS | 31 Juli 2026 | N-PORT |
| IWF · iShares Trust | 0,39% | 1.324.854 SH | 11 Sep. 2026 | Harian |
| CHRI · Global X Funds | 0,38% | 86 NS | 31 Juli 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,37% | 3.398 NS | 31 Juli 2026 | N-PORT |
| IVW · iShares Trust | 0,36% | 755.404 SH | 11 Sep. 2026 | Harian |
| ESLV · Strategy Shares | 0,35% | 142 NS | 31 Juli 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,35% | 1.507 NS | 31 Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,34% | 311.804 SH | 11 Sep. 2026 | Harian |
| ESGG · FlexShares Trust | 0,33% | 1.045 NS | 31 Juli 2026 | N-PORT |
| HAPI · Harbor ETF Trust | 0,33% | 4.509 NS | 31 Juli 2026 | N-PORT |
| AQLT · iShares Trust | 0,32% | 2.890 SH | 11 Sep. 2026 | Harian |
| WRND · New York Life Investments ETF Trust | 0,31% | 92 NS | 31 Juli 2026 | N-PORT |
| MPLY · Strategy Shares | 0,31% | 139 NS | 31 Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,29% | 18 NS | 31 Juli 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,29% | 9 NS | 31 Juli 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,27% | 70.835 SH | 19 Agu 2026 | Harian |
| OEF · iShares Trust | 0,27% | 149.899 SH | 11 Sep. 2026 | Harian |
| LGDX · Tidal Trust III | 0,27% | 1.070 NS | 31 Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,26% | 11.011 SH | 5 Okt. 2026 | Harian |
| ESGV · VANGUARD WORLD FUND | 0,24% | 79.703 SH | 19 Agu 2026 | Harian |
| TOPC · iShares Trust | 0,24% | 215 SH | 11 Sep. 2026 | Harian |
| RSP · Invesco Exchange-Traded Fund Trust | 0,23% | 551.254 SH | 5 Okt. 2026 | Harian |
| IWL · iShares Trust | 0,23% | 13.711 SH | 11 Sep. 2026 | Harian |
| VOO · VANGUARD INDEX FUNDS | 0,22% | 9.198.405 SH | 19 Agu 2026 | Harian |
| VV · VANGUARD INDEX FUNDS | 0,22% | 413.621 SH | 19 Agu 2026 | Harian |
| XVV · iShares Trust | 0,22% | 4.082 SH | 11 Sep. 2026 | Harian |
| PBP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.100 SH | 5 Okt. 2026 | Harian |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,21% | 57.155 SH | 5 Okt. 2026 | Harian |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,20% | 58.287 SH | 19 Agu 2026 | Harian |
| XTR · Global X Funds | 0,20% | 27 NS | 31 Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,20% | 18.003 NS | 31 Juli 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,20% | 13.064 NS | 31 Juli 2026 | N-PORT |
| XRMI · Global X Funds | 0,20% | 277 NS | 31 Juli 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,20% | 1.624 NS | 31 Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,20% | 18.029 NS | 31 Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,19% | 4.463.932 SH | 11 Sep. 2026 | Harian |
| BKLC · BNY Mellon ETF Trust | 0,19% | 30.025 NS | 31 Juli 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 48.668 NS | 31 Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,19% | 349 NS | 31 Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,19% | 5.968 NS | 31 Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,19% | 6.850 SH | 11 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,19% | 11.245.401 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,19% | 29.685 SH | 19 Agu 2026 | Harian |
| TOV · EA Series Trust | 0,19% | 1.423 NS | 31 Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,19% | 19 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,19% | 110.611 NS | 31 Juli 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,18% | 9.810 SH | 11 Sep. 2026 | Harian |
| VOXP · Advisors Series Trust | 0,18% | 30 NS | 31 Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,18% | 15.215 SH | 11 Sep. 2026 | Harian |
| IWB · iShares Trust | 0,18% | 244.032 SH | 11 Sep. 2026 | Harian |
| DYNF · BlackRock ETF Trust | 0,18% | 207.610 SH | 11 Sep. 2026 | Harian |
| USCL · iShares Trust | 0,18% | 14.078 SH | 11 Sep. 2026 | Harian |
| SPUU · Direxion Shares ETF Trust | 0,18% | 1.336 NS | 31 Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,18% | 8.507 NS | 31 Juli 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,17% | 278 SH | 5 Okt. 2026 | Harian |
| IWV · iShares Trust | 0,17% | 97.440 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,17% | 462.408 SH | 11 Sep. 2026 | Harian |
| WINN · Harbor ETF Trust | 0,16% | 5.237 NS | 31 Juli 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0,16% | 11 NS | 31 Juli 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,15% | 2.470 NS | 31 Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,15% | 995 SH | 11 Sep. 2026 | Harian |
| SIZE · iShares Trust | 0,15% | 1.725 SH | 11 Sep. 2026 | Harian |
| SPXL · Direxion Shares ETF Trust | 0,15% | 27.688 NS | 31 Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,14% | 31.794 SH | 11 Sep. 2026 | Harian |
| CRBN · iShares Trust | 0,13% | 4.332 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,13% | 7.742 NS | 31 Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,12% | 112.731 SH | 11 Sep. 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,12% | 294.601 SH | 19 Agu 2026 | Harian |
| DFSU · Dimensional ETF Trust | 0,12% | 7.552 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,11% | 39.089 NS | 31 Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 2.676 SH | 5 Okt. 2026 | Harian |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 2.097 SH | 5 Okt. 2026 | Harian |
| ESGU · iShares Trust | 0,09% | 45.570 SH | 11 Sep. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,07% | 6.700 NS | 31 Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,07% | 17.293 SH | 5 Okt. 2026 | Harian |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,06% | 15.586 SH | 5 Okt. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,04% | 57.069 NS | 31 Juli 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,02% | 141 NS | 31 Juli 2026 | N-PORT |
| DFVX · Dimensional ETF Trust | 0,01% | 141 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 102 NS | 31 Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | -1,41% | -612 NS | 31 Juli 2026 | N-PORT |
ISRG Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
Target Harga 12 Bulan
29 analis · 2026-10-05Target rata-rata $476.34 +17,7%
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
ISRG Panel Analis AI — Pandangan Bullish dan Bearish Debat 2026Q2: Claude, Grok, Gemini, ChatGPT tentang prospek saham
Intuitive Surgical tetap menjadi monopoli berkualitas tinggi, tetapi valuasi premiumnya menyisakan sedikit ruang untuk kesalahan. Claude dan Grok menekankan *moat* perusahaan yang tahan lama dan pendapatan berulang, sementara Gemini dan ChatGPT memperingatkan bahwa rasio P/E 73x membuat saham rentan terhadap perlambatan pertumbuhan apa pun. Panel terbagi mengenai apakah arus keluar institusional baru-baru ini menandakan rotasi struktural atau sekadar kebisingan. Pada akhirnya, kelompok tersebut tetap berhati-hati, sepakat bahwa masa depan saham bergantung pada keberlanjutan volume prosedur.
Babak 1 — Pandangan Awal
Saya melihat kasus *bull* terkuat untuk ISRG karena model *razor-and-blade*-nya mendorong keuntungan tanpa akhir dari basis terpasang sistem da Vinci yang terus berkembang di seluruh dunia. Margin bersih 28,58% berarti Intuitive mengubah hampir sepertiga dari penjualan langsung menjadi laba bersih, jauh di atas pesaing, berkat pendapatan instrumen berulang. Rasio utang terhadap ekuitas berada di 0,0, memberikan perusahaan neraca yang sangat kuat untuk mendanai R&D tanpa risiko *leverage*. EPS TTM telah naik menjadi 7,56, naik dari 7,17 kuartal lalu, menandakan percepatan volume prosedur hingga 2026.
Kasus *bear* pecah jika *hype* bedah robotik memudar di tengah persaingan atau pemotongan penggantian biaya, mengungkap valuasi yang sangat tinggi. P/E TTM pada 73x menjulang di atas pesaing seperti SYK 40x, artinya pasar menghargai kesempurnaan tanpa ruang untuk perlambatan pertumbuhan. Aksi harga baru-baru ini menunjukkan penurunan tajam ke penutupan $512 setelah menyentuh $545, dengan volume melonjak menjadi 8,6 juta saham, mengisyaratkan pengambilan keuntungan. Arus keluar ETF termasuk ISRG menandakan kehati-hatian institusional.
Intuitive Surgical mendominasi pasar robotika bedah dengan ekonomi mendekati monopoli dan *moat* yang terus melebar. Perusahaan ini menghasilkan uang tunai dengan utang nol, margin kotor 66%, dan margin bersih 29% yang tidak dapat ditandingi oleh sebagian besar pesaing alat kesehatan. Ya, saham diperdagangkan pada 73 kali pendapatan tertinggal — jauh di atas pesaing seperti Stryker pada 40x atau Abbott pada 26x — tetapi kelipatan itu mencerminkan bisnis yang mengubah 16% ekuitas pemegang saham menjadi keuntungan dari tahun ke tahun sambil menumbuhkan basis terpasang lebih cepat daripada yang dapat bereaksi oleh pesaing. Basis terpasang bertambah, volume prosedur mengikuti, dan kekuatan harga tetap utuh.
Valuasi ini hampir tidak menyisakan ruang untuk kekecewaan, dan kurva adopsi robotik pada akhirnya akan mendatar. Pada 73x pendapatan, ISRG menghargai eksekusi tanpa cela selama bertahun-tahun — setiap kegagalan dalam pertumbuhan prosedur, kompresi margin dari persaingan, atau ekspansi internasional yang lebih lambat akan memicu kontraksi kelipatan yang tajam. Rasio lancar turun dari 5,6 menjadi 4,97 dalam satu kuartal, menandakan pembakaran kas atau penempatan modal yang perlu diperhatikan. Pesaing seperti Stryker dan Zimmer berinvestasi besar-besaran pada platform pesaing; jika adopsi melambat atau tekanan harga muncul, kelipatan premium ISRG tidak punya tempat untuk bersembunyi.
Intuitive Surgical mendominasi pasar bedah robotik dengan *moat* kompetitif yang tak tergoyahkan yang memungkinkan profitabilitas berulang yang besar. Perusahaan mempertahankan margin kotor sebesar 66,38%. Ini menunjukkan bahwa untuk setiap dolar pendapatan, mereka mempertahankan lebih dari enam puluh enam sen setelah biaya produksi langsung, mencerminkan kekuatan harga yang luar biasa di bidang alat kesehatan. Selain itu, dengan rasio utang terhadap ekuitas nol, mereka beroperasi dengan neraca yang bersih. Ini berarti perusahaan sepenuhnya didanai sendiri dan tidak menghadapi risiko suku bunga, memberikan fleksibilitas keuangan untuk berinvestasi secara agresif dalam platform bedah generasi berikutnya mereka sementara pesaing berjuang dengan *leverage*.
Valuasi tersebut telah menjadi terlalu terlepas dari lintasan pertumbuhan yang mendasarinya untuk membenarkan posisi baru pada tingkat ini. Investor saat ini membayar rasio P/E sebesar 73,09. Ini menyiratkan bahwa pasar mengharapkan eksekusi yang mendekati sempurna selama bertahun-tahun — menyisakan ruang sama sekali untuk bahkan sedikit kegagalan pendapatan atau kemunduran klinis. Selain itu, rasio P/S berada di 20,89. Kelipatan tinggi ini berarti saham dihargai untuk pertumbuhan hiper yang semakin sulit dipertahankan karena mereka mencapai saturasi pasar, membuat harga saham saat ini sangat rentan terhadap kompresi kelipatan jika tingkat pertumbuhan normal ke rata-rata industri.
Saya pikir keunggulan ISRG terletak pada platform robotik yang tahan lama dan ekosistem layanan margin tinggi. ROE TTM: 16,06%. Tingkat itu menandakan ISRG menggunakan ekuitas secara efisien dan dapat mempertahankan pertumbuhan pendapatan. Margin kotor TTM: 66,38%. Margin itu menunjukkan kekuatan harga dan penyerapan biaya tetap yang kuat dalam ekosistem perangkat mereka. Utang/Ekuitas: 0,0. Neraca bebas utang memberikan opsi untuk mendanai R&D, ekspansi, atau pembelian kembali.
Saya pikir ISRG dihargai mahal relatif terhadap risiko pertumbuhan, yang bisa terurai. P/E TTM: 73,0905. Kelipatan yang tinggi itu menghargai pertumbuhan agresif kecuali lintasan pertumbuhan tetap sempurna. P/S TTM: 20,8877. Kelipatan penjualan yang tinggi berarti saham bergantung pada ekspansi *top-line* untuk pengembalian; perlambatan apa pun akan memengaruhi kelipatan. P/B (tahunan): 11,3128. Rasio harga terhadap buku dua digit menunjukkan optimisme berlebihan tentang nilai seperti aset; jika profitabilitas stagnan, saham bisa kembali.
Babak 2 — Tanggapan & Bantahan
Babak 2 — Tanggapan & Bantahan
Claude, poin Anda tentang rasio lancar yang turun dari 5,6 menjadi 4,97 yang menandakan pembakaran kas mengabaikan kekuatan neraca. Pada 4,97, itu masih berarti aset jangka pendek menutupi kewajiban hampir lima kali lipat, memberikan ISRG likuiditas yang cukup untuk mendanai ekspansi da Vinci atau R&D tanpa hambatan. Dengan utang terhadap ekuitas nol, penurunan ini kemungkinan mencerminkan penempatan modal yang cerdas, bukan kesulitan.
Saya pikir Grok salah membaca aksi harga. Ya, kami melihat penurunan ke $512 dan lonjakan volume menjadi 8,6 juta, tetapi itu terjadi pada awal Juli setelah saham sudah naik dari $508 ke $544 dalam tiga minggu sebelumnya. Itu bukan pengambilan keuntungan pada tren — itu adalah fluktuasi mingguan normal pada saham senilai $200 miliar. Tanda sebenarnya adalah EPS naik menjadi 7,56 dari 7,17 kuartal-ke-kuartal. Kenaikan 5% itu penting karena menunjukkan volume prosedur sebenarnya meningkat, bukan stagnan. Arus ETF adalah kebisingan dibandingkan dengan momentum pendapatan.
Grok, poin Anda tentang kehati-hatian institusional yang ditandai oleh arus keluar ETF baru-baru ini adalah bagian penting dari teka-teki yang saya abaikan dalam penilaian awal saya. Ketika Anda melihat lonjakan volume menjadi 8,6 juta saham selama penarikan baru-baru ini, itu menunjukkan bahwa *smart money* secara aktif menyeimbangkan kembali dari valuasi premium ini. Volume itu mewakili pergeseran signifikan dalam dinamika kepemilikan. Jika dukungan institusional melemah, kelipatan 73 kali pendapatan saham menjadi sangat rapuh, karena ada lebih sedikit pembeli yang tersisa untuk membenarkan harga yang agresif untuk perusahaan alat kesehatan.
Claude, argumen *moat* Anda menarik, tetapi P/E tertinggal 73x membuat ISRG rentan jika pertumbuhan atau margin melambat. Tingkat itu menyiratkan pasar mengharapkan bertahun-tahun eksekusi tanpa cela, jadi bahkan sedikit kegagalan dalam volume prosedur atau kekuatan harga dapat memicu kompresi kelipatan yang berarti. Saya menghargai posisi bebas utang dan margin yang kuat, tetapi disiplin valuasi penting di sini — fleksibilitas penempatan modal tidak akan menyelamatkan saham jika jalur pertumbuhan stagnan.
Babak 3 — Bantahan Akhir
Babak 3 — Bantahan Akhir
Claude, saya menolak mengabaikan arus ETF sebagai kebisingan — mereka menandakan kehati-hatian institusional yang nyata yang patut diperhatikan. Berita 25 Maret menandai arus keluar yang signifikan dari ETF termasuk ISRG, tepat saat volume melonjak menjadi 8,6 juta saham pada penurunan ke penutupan $512. Lonjakan itu jauh di atas rata-rata 5,4 juta minggu sebelumnya, menunjukkan distribusi oleh pemegang besar, bukan fluktuasi acak. Pada 73x pendapatan, pemangkasan ini masuk akal jika pertumbuhan prosedur moderat, memperkuat risiko penurunan.
Saya ingin menolak sesuatu yang belum ditantang oleh siapa pun: Gemini, Anda mengatakan dukungan institusional yang melemah membuat kelipatan 73x rapuh, tetapi Anda membaca arus keluar ETF sebagai *smart money* yang menyeimbangkan kembali. Saya akan membaliknya. Monopoli robotika bedah senilai $200 miliar dengan margin kotor 66% dan utang nol tidak akan dijual oleh institusi karena valuasi — itu dipangkas untuk penyeimbangan kembali portofolio atau rotasi sektor. Risiko sebenarnya bukanlah institusi kehilangan keyakinan; melainkan pertumbuhan prosedur benar-benar melambat karena basis terpasang matang. EPS naik 5% kuartal-ke-kuartal, tetapi saya perlu melihat apakah itu dari volume atau hanya penetapan harga. Jika adopsi internasional sudah mendatar dan prosedur AS normal pasca-pandemi, maka 73x pendapatan tidak rapuh karena arus — itu rapuh karena narasi pertumbuhan itu sendiri retak. Itulah kasus *bear* yang layak ditanggapi dengan serius.
Saya ingin menantang penolakan Claude terhadap arus institusional. Claude, Anda menyebut arus keluar ETF sebagai kebisingan, tetapi ketika Anda melihat lonjakan volume 8,6 juta saham baru-baru ini, Anda mengabaikan realitas teknis bagaimana saham *large-cap* berputar. Investor institusional saat ini mengalihkan modal ke saham kesehatan yang berorientasi nilai karena siklus suku bunga stabil. Rotasi keluar dari nama-nama pertumbuhan kelipatan tinggi ini adalah hambatan makro yang nyata bagi Intuitive. Bahkan dengan neraca yang sempurna, saham diperdagangkan pada 73 kali pendapatan, yang merupakan valuasi yang membutuhkan pembelian institusional yang konstan dan berat untuk mempertahankan momentum.
Claude, klaim *moat* Anda menarik, tetapi valuasi adalah penjaga gerbang utama. Saham diperdagangkan pada P/E tertinggal 73x. Itu berarti pasar menghargai eksekusi tanpa cela selama bertahun-tahun, menyisakan sedikit bantalan untuk setiap langkah mundur dalam pertumbuhan prosedur atau kekuatan harga. Bahkan dengan basis terpasang yang dominan, hambatan apa pun dapat memicu kompresi kelipatan yang berarti. Jika hambatan peraturan atau penggantian biaya muncul, premi tersebut sangat rentan.
Prakiraan Harga
| Model | Target 3B | Target 6B | Alasan |
|---|---|---|---|
| Grok | $525.00 | $545.00 | Saya pikir monopoli da Vinci ISRG mendorong kenaikan moderat karena pertumbuhan prosedur mempertahankan kekuatan harga premium di tengah institusi yang waspada. Katalis utama adalah rilis pendapatan Q2 2026 pada akhir Juli, di mana EPS mengalahkan 7,56 pada volume prosedur 15%+ mempercepat kasus *bull*. Satu risiko besar adalah platform robotika Stryker mendapatkan izin FDA, mengikis narasi *moat*. Target 6 bulan saya sebesar $545 menyiratkan P/E 72x pada EPS saat ini, yang berarti pasar masih bertaruh pada ROE 16% yang mendorong ekspansi tanpa *leverage*, tetapi perlambatan apa pun akan membatasinya di sana. |
| Claude | $520.00 | $545.00 | Tesis saya: *Moat* ISRG nyata, tetapi kelipatan P/E 73x adalah kendalanya, bukan basis terpasang. Saham akan dinilai ulang berdasarkan bukti bahwa pertumbuhan volume prosedur bertahan, tidak melambat. Katalis: pendapatan 2026Q2 pada akhir Juli akan menunjukkan apakah kenaikan EPS 5% dari Q1 mencerminkan percepatan volume yang tahan lama atau kebisingan satu kuartal. Jika volume prosedur tetap di atas pertumbuhan 8% tahun-ke-tahun, kelipatan akan bertahan dan saham akan bergerak menuju $545 pada akhir tahun. Risiko: adopsi internasional mendatar lebih cepat dari perkiraan, memaksa manajemen untuk menurunkan panduan pertumbuhan prosedur, memicu kompresi kelipatan 15-20% menjadi 60x pendapatan. Pada 73x, pasar menghargai eksekusi tanpa cela dengan nol margin kesalahan. Harga saat ini $514,59 menyisakan ruang untuk kenaikan moderat jika eksekusi bertahan, tetapi penurunan bersifat asimetris jika pertumbuhan retak. |
| Gemini | $505.00 | $485.00 | Tesis saya adalah bahwa saham akan menghadapi periode kontraksi kelipatan karena investor beralih dari saham pertumbuhan premium tinggi ke nama-nama kesehatan yang lebih defensif. Katalis utama untuk pergerakan penurunan adalah laporan pendapatan berikutnya, di mana setiap perlambatan dalam pertumbuhan volume prosedur akan memaksa analis untuk memangkas ekspektasi mereka yang tinggi. Sebaliknya, risiko terbesar bagi pandangan *bearish* saya adalah terobosan besar dalam penetrasi pasar internasional yang menghidupkan kembali percepatan *top-line*. Intuitive saat ini diperdagangkan pada P/E 73,09. Kelipatan ekstrem ini berarti pasar membayar bertahun-tahun kinerja masa depan yang sempurna, membuat harga saham sangat rentan bahkan terhadap kekecewaan kecil dalam eksekusi triwulanan. |
| Chatgpt | $525.00 | $550.00 | Saya pikir ISRG dapat bergerak lebih tinggi dalam jangka pendek, tetapi valuasi yang tinggi akan membatasi kenaikan. Katalis utama adalah laporan pendapatan kuartalan mendatang yang menunjukkan pertumbuhan prosedur da Vinci yang berkelanjutan dan margin yang stabil. Risikonya adalah adopsi yang lebih lambat dari perkiraan atau hambatan penggantian biaya yang dapat menghambat pertumbuhan dan mengundang kompresi kelipatan. P/E 73 menyiratkan pasar menghargai eksekusi yang mendekati sempurna; kegagalan akan memicu kompresi kelipatan yang berarti. Konon, kekuatan neraca dan margin kotor yang tinggi memberikan penyangga jika siklus berbalik. |
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.